NPLATE subst sèche 500 mcg c solv flac
7680615410024
CH-61541
B02BX04
06.99.0.
Reimbursement limitations:
NPLATE4
Nplate est indiqué chez les patients adultes présentant une thrombopénie immunologique primaire (PTI), réfractaire aux …
1 / 3
google
Details
- Product number
- 6154102
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio cryodesiccata: romiplostimum 500 µg, mannitolum, saccharum, histidinum, polysorbatum 20, acidum hydrochloridum dilutum pro vitro. Solvens: aqua ad iniectabile 1.2 ml.
Articles (1)
Nplate, 500 mcg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
500.0 UG | Substance | Wirkstoff (Principe actif) |
|
SOLV
|
1.2 ML | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 989.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2011
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 61541
- Drug name
- Nplate, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULP
- ATC Code
- B02BX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 29/03/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 06.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NPLATE subst sèche 500 mcg c solv flac
- Description (DE)
- NPLATE Trockensub 500 mcg c Solv Durchstf
- Market launch
- 29/03/2011
- Narcotic (BTM)
- No